U

Viveve Medical, Inc. VIVE

$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Viveve Medical, Inc. was a U.S.-based medical technology company focused on women’s health and non-invasive therapeutic treatments. The company developed and commercialized radiofrequency-based medical technologies intended to address women’s intimate health conditions, including vaginal laxity and aspects of sexual wellness. Viveve operated within the broader medical device and healthcare technology industries, with its business centered on proprietary energy-delivery systems and procedure-based physician services.

The company’s primary commercial product platform was the Viveve System, which used cryogen-cooled monopolar radiofrequency technology designed for use in women’s health procedures. Revenue was historically derived from system sales, disposable treatment tips, and related service activities to healthcare providers and clinics. Viveve positioned itself as a differentiated participant in the women’s health device market by focusing on minimally invasive treatments and physician-administered procedures. Public filings indicate the company evolved from an early-stage medical device developer into a commercialization-stage enterprise, though its operating scale and financial position remained limited relative to larger medical technology peers. Data regarding the company’s current operating status is inconclusive based on available public sources.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, November 10, 2022
Period Date
Friday, September 30, 2022
Next Filing
(est)

Price History

Loading...
52-Week Range22% of range
Low
$0.00
Current
$0.00
High
$0.00
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
--
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
720 696 8100
Address
Building B
Suite 250
345 Inverness Drive South
Englewood, CO 80112
Country
Year Founded

Headlines

There are no news to display.